Here are the top five ASX 200 shares in Macquarie's model growth portfolio

These ASX 200 shares are highly rated by analysts at Macquarie.

a happy investor with a wide smile points to a graph that shows an upward trending share price

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you are looking for portfolio additions, you might want to see the ASX 200 shares that analysts at Macquarie are recommending right now.

The broker has a model portfolio which it believes represents a starting point to form a portfolio with growth characteristics.

Listed below are the top five holdings in the model portfolio at present:

Goodman Group (ASX: GMG)

Taking the top spot in the model portfolio with a weighting of 8.8% is industrial property giant Goodman. Macquarie currently has an outperform rating and $34.84 price target on its shares. It is forecasting earnings per share growth of 12.4% in FY 2025.

Aristocrat Leisure Limited (ASX: ALL)

In second spot in the portfolio with a weighting of 8.1% is this gaming technology company. Macquarie has an outperform rating and $48.50 price target on the ASX 200 growth share. Its analysts believe the company's earnings per share will increase by 9.4% in FY 2024.

CAR Group Limited (ASX: CAR)

Next in line is the company formerly known as Carsales, CAR Group. Macquarie has the auto listings company in its model portfolio with a 7.5% weighting. However, it is worth noting that the broker only has a neutral rating and $32.70 price target on its shares at present. This price target is lower than where its shares trade today.

NextDC Ltd (ASX: NXT)

This data centre operator is in the broker's model growth portfolio with a 7.1% weighting. Macquarie currently has an outperform rating and $20.00 price target on this ASX 200 share.

CSL Limited (ASX: CSL)

Rounding out the top five in Macquarie's model portfolio is this biotherapeutics giant with a weighting of 7.3%. Macquarie currently has an outperform rating and $310.00 price target on its shares. It expects earnings per share growth of 11.1% in FY 2024.

Motley Fool contributor James Mickleboro has positions in CSL and Nextdc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Goodman Group, and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL, Car Group, and Goodman Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A woman stands at her desk looking a her phone with a panoramic view of the harbour bridge in the windows behind her with work colleagues in the background.
Growth Shares

Analysts say these ASX 200 shares could rise 30% to 40%

Big returns could be on offer with these growing stocks.

Read more »

Four piles of coins, each getting higher, with trees on them.
Growth Shares

2 ASX 200 shares that could be top buys for growth

These two businesses have an exciting future.

Read more »

Man pointing at a blue rising share price graph.
Growth Shares

The 3 biggest ASX multibaggers in 2025

These billion-dollar ASX companies have delivered eye-catching multibagger returns in 2025.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Growth Shares

These world class ASX 200 growth shares could rise 40% to 80%

These high-quality shares are seriously undervalued according to brokers.

Read more »

A male ASX investor sits cross-legged with a laptop computer in his lap with a slightly crazed, happy, excited look on his face while next to him a graphic of a rocket shoots upwards with graphics of stars scattered around it
Healthcare Shares

Up 10x since July, could this hot ASX stock be the next Droneshield?

Investors chase asymmetric upside and 4DMedical is one of the ASX's hottest stocks right now.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Growth Shares

3 ASX mid-cap rockets that could become future blue chips

These stocks could be destined for big things in the future according to analysts.

Read more »

People with their hands underneath each other's hands holding a plant.
Growth Shares

2 ASX growth shares I'd buy today for growth and income

Both of these businesses are delivering excellent progress.

Read more »

A man has a surprised and relieved expression on his face.
Growth Shares

These exciting ASX 200 growth shares could rise 60% to 100% in 2026

Analysts believe these shares could be dirt cheap and strong buys right now.

Read more »